IgG Subclasses
Immunoglobulins are the major component of humoral immunity and account for 11-20% of the total serum proteins. Around 80% of the circulating immunoglobulins are IgGs. IgGs are further divided into four subclasses: IgG1, IgG2, IgG3, and IgG4. Even though 95% amino acid homology exists between the IgGs, each of them has a unique profile concerning antigen recognition, complement activation, immune complex formation, activation of effector cells, placental transport, and half-life in plasma. This uniqueness is conferred by the constant region of the heavy chain which is encoded for by the (C) gene on chromosome 14. The proportion of IgG1, IgG2, IgG3, and IgG4 in serum is approximately 65%, 25%, 6% and 4%, respectively.
IgGs are predominantly active in the secondary immune response. Elevated IgGs are often observed in chronic infections such as hepatitis and auto-immune disorders. IgG1 and IgG3 are known to be increased in early HIV infection. Increased levels of IgG4 are consistent with allergen-associated conditions such as bronchial asthma, but its measurement does not provide diagnostic value. A decrease in the level of total IgG predisposes patients to increased infection risk. It can be either inherited (example: hereditary hypogammaglobulinemia) or acquired. IgG1 and IgG3 deficiency is predominantly associated with recurring infection of the lower respiratory tract and IgG2 and IgG4 deficiency usually co-exist and is associated with oto-sino-pulmonary infections particularly from polysaccharide-capsulated organisms like Streptococcus pneumoniae and Haemophilus influenzae. Other conditions associated with low serum IgG are Wiskott-Aldrich syndrome, Ataxia telangiectasia, and Mickulicz’s disease.
ELISA, RIA, Nephelometry, and immunofluorescence are widely performed for IgG subclass measurement. Undetectable levels of one or more IgG subclasses may indicate heterozygous mutation(s) of the C gene in chromosome 14. Abnormal IgG subclass levels do not necessarily indicate an immunodeficiency exists unless there is clinical evidence of increased infections or an inadequate response to vaccination.
- Evaluation for immunodeficiency, auto-immune disorders, and chronic or recurrent infections
- Evaluation for humoral immunodeficiency or combined immunodeficiency (cellular and humoral)
- Investigating recurrent infections of unknown etiology
- Monitoring prognosis of desensitization therapy in allergen-associated diseases
- Assessment of side-effects of radiotherapy and chemotherapy
Increased in:
- Chronic infections
- Multiple myeloma
- Multiple sclerosis
- Inherited hypergammaglobulinemia
- HIV: IgG1, IgG3
- Mickulicz’s disease: IgG4
- Systemic Lupus Erythematosus (SLE)
- Other auto-immune diseases.
Decreased in:
- Common variable immunodeficiency (CVID): IgG1, IgG2
- Wiskott- Aldrich syndrome: IgG2, IgG3
- Ataxia-telangiectasia: IgG2, IgG3, IgG4
- HIV: IgG2, IgG4
| Total IgG (g/L) – Age Group | Reference Range |
| 0-1 year | 1.0-8.4 |
| 1-3 years | 3.1-10.2 |
| 3-6 years | 3.8-13.6 |
| 6-12 years | 4.6-15.7 |
| 12-16 years | 5.0-16.5 |
| >16 years | 6.9-17.9 |
| IgG1 (g/L) – Age Group | Reference Range |
| 0-1 year | 1.8-7.7 |
| 1-3 years | 2.5-7.7 |
| 3-6 years | 3.2-9.5 |
| 6-12 years | 3.6-10.8 |
| 12-16 years | 3.4-11.1 |
| >16 years | 3.4-10.0 |
| IgG2 (g/L) – Age Group | Reference Range |
| 0-1 year | 0.25-2.4 |
| 1-3 years | 0.3-3.0 |
| 3-6 years | 0.5-3.4 |
| 6-12 years | 0.6-4.2 |
| 12-16 years | 0.7-5.0 |
| >16 years | 1.0-5.4 |
| IgG3 (g/L) – Age Group | Reference Range |
| 0-1 year | 0.2-0.8 |
| 1-3 years | 0.15-0.8 |
| 3-6 years | 0.1-1.2 |
| 6-12 years | 0.2-1.3 |
| 12-16 years | 0.2-1.5 |
| >16 years | 0.2-1.7 |
| IgG4 (g/L) – Age Group | Reference Range |
| 0-1 year | 0-0.6 |
| 1-3 years | 0-0.8 |
| 3-6 years | 0-1.1 |
| 6-12 years | 0-1.2 |
| 12-16 years | 0-1.3 |
| >16 years | 0.2-1.4 |
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- Immunol Rev. 2000;178:99–110. [PMID: 11213812]
- Front Immunol.2014;5:520. [PMID: 25368619]
- Clin Chem. 2018;64:735-742 [PMID: 29352044]
- Clin Chem. 2014 Aug;60(8):1080-8. [PMID: 24799527]
- Dr. A.J. Human IgG Subclasses Useful Diagnostic Markers for Immunocompetence. 3rd edition. 2008